Active Shortage

PHENYTOIN SODIUM INJECTION USP

HIKMA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of PHENYTOIN SODIUM INJECTION USP in Canada?

Yes. PHENYTOIN SODIUM INJECTION USP 50MG has an active shortage reported to Health Canada (last updated October 9, 2026).

Why is PHENYTOIN SODIUM INJECTION USP not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will PHENYTOIN SODIUM INJECTION USP be available again?

The manufacturer's estimated resolution date is December 1, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file3 products · 1 same form & route

Expected resolution~19 days remaining (estimate)

Affected strength50MG

Report last updated2026-10-09

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

PHENYTOIN SODIUM INJECTION USP

SANDOZ CANADA INCORPORATED

50MG · DIN 00780626

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

CEREBYX

SEARCHLIGHT PHARMA INC

75MG · DIN 02230988

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

DILANTIN

BGP PHARMA ULC

30MG · DIN 00022772

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02431378

Strength

50MG

Dosage Form

SOLUTION

Route

INTRAVENOUS INTRAMUSCULAR

Active Ingredient

PHENYTOIN SODIUM

See all PHENYTOIN SODIUM products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-10-09

Active Shortage

Disruption of the manufacture of the drug.

Other Products from HIKMA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION USP

9MG · DIN 02304341

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02459906

ATROPINE INJECTION BP

0.6MG · DIN 02432196

ATROPINE INJECTION BP

0.4MG · DIN 02432188

AZACITIDINE FOR INJECTION

100MG · DIN 02507668

BACLOFEN INJECTION

0.05MG · DIN 02457059